November 25 (SeeNews) - Polish drug discovery company Selvita said it agreed to acquire Croatian contract research organisation (CRO) Fidelta from Belgium's Galapagos for 31.2 million euro ($37 million) in cash plus the customary adjustments for net cash and working capital.